Literature DB >> 1704137

Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine.

T Kalebic1, A Kinter, G Poli, M E Anderson, A Meister, A S Fauci.   

Abstract

The effects of glutathione (GSH), glutathione ester (GSE), and N-acetyl-L-cysteine (NAC) on the induction of human immunodeficiency virus (HIV) expression were investigated in the chronically infected monocytic U1 cell line, a previously described cellular model for HIV latency. U1 cells constitutively express low levels of virus, which can be increased by phorbol 12-myristate 13-acetate (PMA), tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), and other inducers. GSH, GSE, and NAC suppressed in a dose-dependent fashion the induction of HIV expression mediated by PMA, TNF-alpha, and IL-6, in the absence of cytotoxic or cytostatic effects. Reverse transcriptase activity, inducible by PMA, TNF-alpha, or IL-6, was decreased by 80-90% after pretreatment with GSH, GSE, or NAC. The induction of total HIV protein synthesis was also decreased appreciably after pretreatment with GSH, GSE, or NAC. The accumulation of HIV mRNA was substantially suppressed after pretreatment with NAC but to a lesser extent after pretreatment with GSH or GSE. Although PMA induces the expression of TNF-alpha in U1 cells, the suppressive effect of GSH, GSE, and NAC on PMA-induced HIV expression in U1 cells was not associated with the inhibition of TNF-alpha expression. The present findings, which elucidate relationships between cellular GSH and HIV expression, suggest that therapy with thiols may be of value in the treatment of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704137      PMCID: PMC50939          DOI: 10.1073/pnas.88.3.986

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression.

Authors:  K A Clouse; P B Robbins; B Fernie; J M Ostrove; A S Fauci
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

2.  Systemic glutathione deficiency in symptom-free HIV-seropositive individuals.

Authors:  R Buhl; H A Jaffe; K J Holroyd; F B Wells; A Mastrangeli; C Saltini; A M Cantin; R G Crystal
Journal:  Lancet       Date:  1989-12-02       Impact factor: 79.321

3.  Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate.

Authors:  T M Folks; J Justement; A Kinter; S Schnittman; J Orenstein; G Poli; A S Fauci
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

4.  Complexity of the primary genetic response to mitogenic activation of human T cells.

Authors:  P F Zipfel; S G Irving; K Kelly; U Siebenlist
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

Review 5.  Glutathione.

Authors:  A Meister; M E Anderson
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

6.  Stimulation of neutrophils by tumor necrosis factor.

Authors:  S J Klebanoff; M A Vadas; J M Harlan; L H Sparks; J R Gamble; J M Agosti; A M Waltersdorph
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

7.  Interleukin 6 primes human neutrophil and monocyte oxidative burst response.

Authors:  A Kharazmi; H Nielsen; C Rechnitzer; K Bendtzen
Journal:  Immunol Lett       Date:  1989-05       Impact factor: 3.685

8.  The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4.

Authors:  S M Schnittman; M C Psallidopoulos; H C Lane; L Thompson; M Baseler; F Massari; C H Fox; N P Salzman; A S Fauci
Journal:  Science       Date:  1989-07-21       Impact factor: 47.728

9.  Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1.

Authors:  P Roux-Lombard; C Modoux; A Cruchaud; J M Dayer
Journal:  Clin Immunol Immunopathol       Date:  1989-03

10.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more
  57 in total

Review 1.  Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.

Authors:  K J Connolly; S M Hammer
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

Review 2.  Comparative nutrition and metabolism: explication of open questions with emphasis on protein and amino acids.

Authors:  David H Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

3.  Analysis of Raw Biofluids by Mass Spectrometry Using Microfluidic Diffusion-Based Separation.

Authors:  Joshua Heinemann; Brigit Noon; Daniel Willems; Katherine Budeski; Brian Bothner
Journal:  Anal Methods       Date:  2016-12-06       Impact factor: 2.896

4.  Perfluorooctane Sulfonate (PFOS) Produces Dopaminergic Neuropathology in Caenorhabditis elegans.

Authors:  Shreesh Raj Sammi; Rachel M Foguth; Claudia Sofía Nieves; Chloe De Perre; Peter Wipf; Cynthia T McMurray; Linda S Lee; Jason R Cannon
Journal:  Toxicol Sci       Date:  2019-12-01       Impact factor: 4.849

Review 5.  Potential therapeutics of vitamin E (tocopherol) in AIDS and HIV.

Authors:  Y Wang; R R Watson
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

6.  Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells.

Authors:  A Bergamini; M Capozzi; L Ghibelli; L Dini; A Salanitro; G Milanese; T Wagner; S Beninati; C D Pesce; C Amici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Glutamine preserves liver glutathione after lethal hepatic injury.

Authors:  R W Hong; J D Rounds; W S Helton; M K Robinson; D W Wilmore
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

8.  Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication.

Authors:  H J Prochaska; Y Yeh; P Baron; B Polsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B.

Authors:  L Folgueira; A Algeciras; W S MacMorran; G D Bren; C V Paya
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  IFN-ε protects primary macrophages against HIV infection.

Authors:  Carley Tasker; Selvakumar Subbian; Pan Gao; Jennifer Couret; Carly Levine; Saleena Ghanny; Patricia Soteropoulos; Xilin Zhao; Nathaniel Landau; Wuyuan Lu; Theresa L Chang
Journal:  JCI Insight       Date:  2016-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.